Showing results (231-240 of 2,276) with videos related to

Sort By:
Pageof 228
Diabetes & Metabolism|July 14, 2001
[Insulin sensitivity and stress]A Avignon, L Monnier
Diabetes & Metabolism|September 8, 2001
Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insightsF Mauvais-Jarvis, F Andreelli, H Hanaire-Broutin, et al.
Diabetes & Metabolism|September 8, 2001
Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial functionB Guerci, A Kearney-Schwartz, P Böhme, et al.
Diabetes & Metabolism|September 19, 2019
Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trialsF J Tinahones, U Laufs, B Cariou, et al.
Diabetes & Metabolism|September 21, 2019
Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)M S Capehorn, A-M Catarig, J K Furberg, et al.
Diabetes & Metabolism|January 17, 2021
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the "Gordian Knot"?Louis Monnier, Claude Colette, David Owens
Diabetes & Metabolism|February 24, 2019
Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetesM B Christensen, P Gæde, E Hommel, et al.
Diabetes & Metabolism|May 10, 2011
Patients' impatience is an independent determinant of poor diabetes controlG Reach, A Michault, H Bihan, et al.
Diabetes & Metabolism|April 5, 2011
Ethnic differences in the relationship of prediabetes with the presence of target-organ diseaseM S Player, V A Diaz, A G Mainous, et al.
Diabetes & Metabolism|April 9, 2011
Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)D Bruttomesso, M Bonomo, S Costa, et al.
Pageof 228